Respiratory mucosal immunity against SARS-CoV-2 following mRNA vaccination

SARS-CoV-2 mRNA vaccination induces robust humoral and cellular immunity in the circulation; however, it is currently unknown whether it elicits effective immune responses in the respiratory tract, particularly against variants of concern (VOCs), including Omicron. We compared the SARS-CoV-2 S-speci...

Descripción completa

Detalles Bibliográficos
Autores principales: Tang, Jinyi, Zeng, Cong, Cox, Thomas M., Li, Chaofan, Son, Young Min, Cheon, In Su, Wu, Yue, Behl, Supriya, Taylor, Justin J., Chakraborty, Rana, Johnson, Aaron J., Schiavo, Dante N., Utz, James P., Reisenauer, Janani S., Midthun, David E., Mullon, John J., Edell, Eric S., Alameh, Mohamad G., Borish, Larry, Teague, William G., Kaplan, Mark H., Weissman, Drew, Kern, Ryan, Hu, Haitao, Vassallo, Robert, Liu, Shan-Lu, Sun, Jie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for the Advancement of Science 2022
Materias:
Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9348751/
https://www.ncbi.nlm.nih.gov/pubmed/35857583
http://dx.doi.org/10.1126/sciimmunol.add4853

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9348751/
https://www.ncbi.nlm.nih.gov/pubmed/35857583
http://dx.doi.org/10.1126/sciimmunol.add4853

Ejemplares similares